报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 52.81% | 11.45% | 8.33% | 40/54 | 69.26% | 我武生物 | 95.26% | 行业排名> |
2024-06-30 | 48.75% | 1.6% | 15.96% | 42/54 | 68.54% | 西藏药业 | 95.7% | 行业排名> |
2024-03-31 | 42.04% | -5.14% | -8.99% | 43/54 | 69.17% | 康华生物 | 95.85% | 行业排名> |
2023-12-31 | 46.19% | 7.68% | -2.51% | 39/54 | 68.33% | 我武生物 | 95.26% | 行业排名> |
2023-09-30 | 47.39% | 11.81% | -1.25% | 39/54 | 68.07% | 我武生物 | 95.4% | 行业排名> |
2023-06-30 | 47.98% | 29.72% | 8.27% | 39/54 | 63.32% | 华兰疫苗 | 101.02% | 行业排名> |
2023-03-31 | 44.32% | 45.78% | 3.31% | 39/54 | 69.48% | 华兰疫苗 | 100.22% | 行业排名> |
2022-12-31 | 42.9% | 29.26% | 1.23% | 42/54 | 68.27% | 我武生物 | 95.39% | 行业排名> |
2022-09-30 | 42.38% | 24.51% | 14.57% | 41/54 | 71.28% | 我武生物 | 95.63% | 行业排名> |
2022-06-30 | 36.99% | 7.87% | 21.67% | 43/54 | 69.18% | 我武生物 | 95.75% | 行业排名> |
2022-03-31 | 30.4% | -22.51% | -8.4% | 41/54 | 71.63% | 华兰疫苗 | 98.39% | 行业排名> |
2021-12-31 | 33.19% | -33.74% | -2.49% | 46/54 | 72.33% | 百奥泰 | 95.74% | 行业排名> |
2021-09-30 | 34.04% | -32.83% | -0.74% | 43/54 | 73.87% | 我武生物 | 95.89% | 行业排名> |
2021-06-30 | 34.29% | -33.88% | -12.6% | 44/54 | 73.72% | 百奥泰 | 96.33% | 行业排名> |
2021-03-31 | 39.23% | -7.76% | -21.67% | 36/54 | 73.03% | 义翘神州 | 96.83% | 行业排名> |
2020-12-31 | 50.09% | 16.91% | -1.15% | 36/54 | 71.61% | 义翘神州 | 96.88% | 行业排名> |
2020-09-30 | 50.67% | 2% | -2.28% | 29/54 | 73.64% | 义翘神州 | 96.56% | 行业排名> |
2020-06-30 | 51.86% | 28.83% | 21.92% | 36/54 | 88.2% | 华兰疫苗 | 707.43% | 行业排名> |
2020-03-31 | 42.54% | 2% | -0.73% | 28/54 | 70.26% | 我武生物 | 95.6% | 行业排名> |
2019-12-31 | 42.85% | 2% | 6.45% | 38/54 | 72.44% | 我武生物 | 96.43% | 行业排名> |
2019-06-30 | 40.25% | 2% | 2% | 25/54 | 69.35% | 我武生物 | 96.51% | 行业排名> |